Praxis Precision Medicines Inc (PRAX)

R&D Expense Growth

75.26%

Fiscal year · Period ending:

PRAX logo

PRAX R&D Expense Growth

Latest reported75.26%
PRAX FY R&D Growth (YoY) (0.00% → 75.26%)
High-resolution chart · PNG

PRAX r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Praxis Precision Medicines Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
75.2574%
75.6598%
-44.0364%
28.9239%
167.3804%
52.167%
57.051%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.